Meningitis B vaccine could offer broad protection

A vaccine against meningitis B could have the potential to protect older babies against multiple strains of the bacteria, UK research suggests.

The study of 60 infants, aged six to eight months, showed that more than 95 per cent of infants generated a protective immune response against three strains of meningitis B one month after receiving two doses of the vaccine.

Study researcher Dr Mathew Snape, from the Oxford Vaccine Group at the University of Oxford, said: ‘These are encouraging new findings that indicate the Novartis meningitis B vaccine may offer older, as well as younger, infants protection against multiple strains of meningococcal B bacteria.'

The findings were presented yesterday at the 16th International Pathogenic Neisseria Conference in Rotterdam, Netherlands.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus